Table 1. Induction therapy, valganciclovir and antibiotic use after kidney transplantation.

	Controls (N = 19), %	NODAT (N = 15), %	Diabetics (N = 16), %	Total (N = 50), %	Pa
Induction therapy
Polyclonal Anti-Lymphocyte Ig	77	93	80	83	0.5
Basiliximab	24	7.1	20	11
Valganciclovir for the treatment of CMV infection before M3-9 sample	58	87	73	71	0.2
Antibiotic treatment before M3-9 sample (other than antibioprophylaxis)	21	36	40	31	0.5

Ig: immunoglobulin

^aThe P value shown in the table is the result of X² tests. CMV: cytomegalovirus.